634P the Ave-Rec Phase II Trial of PD-L1/PD-1 Blockade with Avelumab Plus Chemoradiotherapy for Resectable ESMO High Risk Rectal CancersM. Michael,R. Wong,S. Gill,A. Strickland,N. Pavlakis,J. Shapiro,E. Link, M. Farrell,S. Ngan,A. Heriot,D. Goldstein,C. Mitchell,K. Wilson, M. Mui,R. Ramsay,E. SegelovAnnals of Oncology（2023）引用 0|浏览8AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
